Teladoc: Back In The Doldrums After Another Tough Year (Rating Downgrade)
Teladoc Health, Inc.'s stock has declined significantly, from a high of $14 per share in February to $7 per share, with ongoing financial struggles and underperformance in key segments. The company reported a net loss of $1 billion in 2024, with declining revenues in its BetterHelp segment and minimal growth in Integrated Care. Despite efforts to cut costs and new initiatives like the Catapult Health acquisition and a partnership with Eli Lilly, Teladoc's value proposition remains unclear.
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction
With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. It's a great strategy, but it's essential to avoid those companies that only look undervalued but actually aren't.
Why Is Teladoc (TDOC) Down 9.9% Since Last Earnings Report?
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
Teladoc (TDOC) Flat As Market Sinks: What You Should Know
Teladoc (TDOC) reachead $8.64 at the closing of the latest trading day, reflecting no change compared to its last close.
Teladoc (TDOC) Exceeds Market Returns: Some Facts to Consider
In the latest trading session, Teladoc (TDOC) closed at $8.49, marking a +1.19% move from the previous day.
Does Teladoc's $65 Million Acquisition of Catapult Health Make the Stock a Buy?
Telemedicine specialist Teladoc Health (TDOC 1.53%) has been a terrible investment over the past three years. Once the company's pandemic-fueled business boom cooled down, its revenue and visit growth slowed down considerably while it remained unprofitable.
Teladoc Expands Specialty Care Access With Carrum Health Partnership
TDOC partners with Carrum Health in a bid to expand access to specialty care.
Teladoc Doubles Down on Connected Care With New Partnerships
With more than 93 million members, deeper integration of services could lead to higher utilization for TDOC.
Teladoc (TDOC) Advances While Market Declines: Some Information for Investors
Teladoc (TDOC) closed at $9 in the latest trading session, marking a +0.78% move from the prior day.
Teladoc Boosts Weight Care Access With LillyDirect, Aids Growth
TDOC expands weight care access with LillyDirect, boosting growth by offering affordable GLP-1 medications like Zepbound, enhancing patient outcomes and engagement.
Teladoc Health Enhances Prism Platform for Better Virtual Care
TDOC upgrades its Prism platform with AI-powered tools, improved referrals and data integration, enhancing care coordination to bolster its member base.
Teladoc Health, Inc. (TDOC) TD Cowen 45th Annual Health Care Conference (Transcript)
Teladoc Health, Inc. (NYSE:TDOC ) TD Cowen 45th Annual Health Care Results Conference March 3, 2025 10:30 AM ET Company Participants Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Charles Rhyee - TD Cowen Charles Rhyee Thank you everyone for being here for the next session here. We're pleased to have Teladoc Health with us today.
